4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Aims Stereotactic body radiotherapy (SBRT) for ventricular tachycardias (VTs) could be an
option after failed catheter ablation. In this study, we analysed the long-term efficacy and …

Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival
in patients at risk for sudden cardiac death, but complications remain an important …

Background Treatment strategies to prevent ventricular tachycardia (VT) in patients with an
implantable cardioverter-defibrillator (ICD) include antiarrhythmic drugs (AADs) and catheter …

Ventricular tachycardia (VT) is a potentially fatal cardiac rhythm disorder. Implantable
cardioverter defibrillators (ICDs) are the primary management strategy for VT and have been …

Background The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD)
eliminates the need for transvenous leads, and therefore has the potential to improve lead …

Background It is unknown whether implantable cardioverter-defibrillator (ICD) discharges
actively contribute to a worse prognosis independent of the underlying arrhythmia. There is …

To develop a suite of quality indicators (QIs) for the management of patients with ventricular
arrhythmias (VA) and the prevention of sudden cardiac death (SCD). The Working Group …